Key Factors Fueling the Growth of the Whole Genome And Exome Sequencing Market in 2025: The Surge In Demand For Personalized Medicine Boosts The Whole Genome And Exome Sequencing Market

Global Whole Genome And Exome Sequencing Market

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Anticipated CAGR of the Whole Genome And Exome Sequencing Market, and What Factors Will Drive It?

The market size for whole genome and exome sequencing has seen an explosive growth in recent times. Projections suggest an increase from $2.02 billion in 2024 to $2.52 billion in 2025, leading to a compound annual growth rate (CAGR) of 24.5%. The surge experienced in the historical period can be linked to factors like reduced sequencing costs, an uptick in genetic disorders, clinical implementation, the availability of genomic data repositories, and progress in bioinformatics.

The market size for whole genome and exome sequencing is predicted to experience a substantial surge in the upcoming years, ballooning to $6.11 billion in 2029 with a compound annual growth rate (CAGR) of 24.8%. This growth during the forecast period may be due to factors such as the initiatives in population genomics, the increasing need for precision medicine, the progression in single-cell sequencing, the growth of non-invasive prenatal testing (NIPT), and its use in the research of rare disorders. The forecast period will also witness key developments such as heightened clinical adoption, rapid progression in sequencing technologies, rise in population-scale genomic studies, utilization of artificial intelligence (AI) and machine learning (ML), and growth in applications in the field of oncology.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13957&type=smp

What are the Fundamental Drivers and Innovations Shaping the Whole Genome And Exome Sequencing Market?

Anticipations for an upsurge in personalized medicine is predicted to spur the growth of the whole genome and exome sequencing market moving forward. This form of medicine is structured to individualize healthcare strategies and procedures in alignment with each patient’s unique genetics, environment, and lifestyle. Whole genome and exome sequencing play a critical role in personalized medicine by providing an all-inclusive genetic map of the individual, enabling healthcare strategies and procedures to be curated based on their distinctive genetic, environmental, and lifestyle aspects. To evidence this, the Personalized Medicine Coalition (PMC), a US-based institution that advances the knowledge and application of personalized medicine, reported in October 2022 that over 75,000 genetic testing products and 300 individualized medicines are projected to penetrate the market in 2022. Additionally, the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) granted approval for 37 new molecular entities (NMEs) in 2022, of which approximately 34%, or 12 entities, fall into the personalized classification. As such, the increasing call for personalized medicine is contributing to the expansion of the whole genome and exome sequencing market.

How Is the Whole Genome And Exome Sequencing Market Segmented?

The whole genome and exome sequencingmarket covered in this report is segmented –

1) By Product Type: Kits; Instruments

2) By Workflow: Whole Genome Sequencing (WGS); Whole Exome Sequencing (WES)

3) By Applications: Diagnostics; Cancer; Monogenic Disorders; Diabetes; Drug Discovery And Development; Personalized Medicine; Agriculture And Animal Research; Other Applications

4) By End user: Research Center; Academic And Government Institutions; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End Users

Subsegments:

1) By Kits: Library Preparation Kits; Target Enrichment Kits; DNA Extraction Kits

2) By Instruments: Next-Generation Sequencing (NGS) Systems; Sanger Sequencing Systems; Third-Generation Sequencing Systems

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=13957&type=smp

Which Regions Are Driving the Next Phase of the Whole Genome And Exome Sequencing Market Growth?

North America was the largest region in the whole genome and exome sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the whole genome and exome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Trends Are Shaping the Future of the Whole Genome And Exome Sequencing Market?

Leading corporations within the whole genome and exome sequencing industries are intensifying their focus towards the development of cutting-edge technologies, such as the ultra-fast NGS (next-generation sequencing) analysis, for a stronger competitive position. With the advent of this innovative technology, ultra-fast NGS analysis, a considerable reduction in the time needed for genomic data analysis has become possible due to its ability to process data at an unprecedented speed. A case in point, QIAGEN Digital Insights (QDI), a bioinformatics firm based in the US, launched an ultra-fast NGS analysis platform in January 2023. This unique platform presents benefits like processing a whole genome in just 25 minutes at a cost of $1 in terms of cloud computing expenses, reinforcing affordability, efficiency, and scalability. This technological breakthrough considerably accelerates the speed of genomic data analysis and its accessibility, proving immensely vital in the whole genome and exome sequencing industry by accelerating decision-making processes and advocating a broader application of personalized medicine.

View the full report here:

https://www.thebusinessresearchcompany.com/report/whole-genome-and-exome-sequencing-global-market-report

How Is the Whole Genome And Exome Sequencing Market Defined and What Are Its Core Parameters?

Whole genome sequencing (WGS) and exome sequencing (ES) are comprehensive genetic analysis techniques that involve determining the complete DNA sequence of an organism’s genome and sequencing the protein-coding regions of the genome. These analyses are used to sequence a person’s DNA for diagnosing genetic diseases and identifying cancer mutations.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13957

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model